Prehabilitation of Elderly Patients With Frailty Syndrome Before Elective Surgery (PRAEP-GO)
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jun 1, 2020
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
The PRAEP-GO trial is studying how a special program can help elderly patients who are frail before they undergo elective surgery. The program includes a three-week plan to prepare patients physically and mentally, and it starts with a meeting to discuss treatment options. Researchers want to see if this approach makes it easier for patients to recover after surgery and whether it reduces their need for extra care a year later. They are looking for about 1,400 participants across different centers in the country.
To be eligible for this study, you must be at least 70 years old and scheduled for surgery that will take more than an hour under anesthesia. You also need to show signs of frailty, which means you might have some health challenges that could affect your recovery. Participants will receive personalized support during the prehabilitation program, and their progress will be closely monitored. This research is important because it aims to improve the quality of life for older patients after surgery and to see if preparing them in this way is cost-effective.
Gender
ALL
Eligibility criteria
- Study patients:
- Inclusion Criteria:
- • Age ≥ 70 years
- • Consent by Patient or Legal Representative
- • Elective surgery planned
- • Expected anesthesia duration≥ 60 min
- • Statutory health insurance
- • Frailty syndrome (≥1 positive out of 5 standardized parameters according to the Physical Frailty Phenotype according to Fried et. al.)
- Exclusion Criteria:
- • Severe cardiac or pulmonary disease (NYHA IV, Gold IV)
- • Intracranial interventions
- • Moribund patients (palliative situation)
- • Not enough language skills
- • Participation in another interventional rehabilitation study or other interventional clinical trial that has not been approved by the study management committee (Exception: Participation in adjuvant intervention study)
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Berlin, , Germany
Greifswald, , Germany
Bad Oeynhausen, , Germany
München, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Frankfurt/Oder, , Germany
Kremmen, , Germany
Lübeck, , Germany
München, , Germany
München, , Germany
Nauen, , Germany
Rathenow, , Germany
Patients applied
Trial Officials
Claudia Spies, Prof., MD
Study Chair
Charite University, Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials